Experienced in Metastatic Brain Tumor

Christof M. Kramm

Robert Koch Str. 40, 
Goettingen, NI, DE 
Experienced in Metastatic Brain Tumor
Robert Koch Str. 40, 
Goettingen, NI, DE 
OverviewLocationsClinical Research

Overview

Christof Kramm practices in Goettingen, Germany. Mr. Kramm is rated as an Experienced expert by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Glioma, Gliomatosis Cerebri, Diffuse Midline Glioma H3 K27M-Mutant, and Brain Stem Cancer.

His clinical research consists of co-authoring 110 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Metastatic Brain Tumor.

Gender
Male

Locations

Robert Koch Str. 40, Goettingen, NI 37075, Germany
Other Locations
Ernst Grube Str. 40, Halle, NI 06120, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2025
Intervention Type: Drug
Study Drugs: Rituximab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide, Methotrexate, Prednisolone, Vincristine
Study Phase: Phase 3
A Phase 1/2, Single-arm Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
A Phase 1/2, Single-arm Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
Enrollment Status: Active_not_recruiting
Publish Date: September 23, 2024
Intervention Type: Drug
Study Drug: Avapritinib
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

110 Total Publications

Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM.
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM.
Journal: Acta neuropathologica
Published: May 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kramm's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile